 |
|
U of T researchers reveal Epstein-Barr virus protein contributes to cancer
October 07, 2008TORONTO, ON - Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development.
The study findings are published in the October 3rd edition of the journal PLoS Pathogens and describes a novel mechanism by which viral proteins contribute to carcinogenesis.
EBV is a common herpes virus whose latent infection is strongly associated with several types of cancer including NPC, a tumor that is endemic in several parts of the world. With NPC only a few EBV proteins are expressed, including EBNA1. EBNA1 is required for the persistence of the EBV genomes; however, whether or not EBNA1 directly contributes to the development of tumors has not been clear, until now.
The study conducted by Lori Frappier a professor of molecular genetics and her team at the University of Toronto examined PML nuclear bodies and proteins in EBV-positive and EBV-negative NPC cells. Manipulation of EBNA1 levels in each cell type clearly showed that EBNA1 expression induces the loss of PML proteins and PML nuclear bodies through an association of EBNA1 with the PML bodies. PML nuclear bodies are known to have tumor-suppressive effects due to their roles in regulating DNA repair and programmed cell death, and accordingly, EBNA1 was shown to interfere with these processes.
"The findings support an important role for EBNA1 in the development of NPC, in which EBNA1-mediated disruption of PML nuclear bodies promotes the survival of cells with DNA damage," said Frappier. "Since EBNA1 is expressed in all EBV-associated tumors, including B-cell lymphomas and gastric carcinoma, these findings raise the possibility that EBNA1 could play a similar role in the development of these cancers. The cellular effects of EBNA1 in other EBV-induced cancers will require further investigation."
University of Toronto
The study conducted by Lori Frappier a professor of molecular genetics and her team at the University of Toronto examined PML nuclear bodies and proteins in EBV-positive and EBV-negative NPC cells. Manipulation of EBNA1 levels in each cell type clearly showed that EBNA1 expression induces the loss of PML proteins and PML nuclear bodies through an association of EBNA1 with the PML bodies. PML nuclear bodies are known to have tumor-suppressive effects due to their roles in regulating DNA repair and programmed cell death, and accordingly, EBNA1 was shown to interfere with these processes.
"The findings support an important role for EBNA1 in the development of NPC, in which EBNA1-mediated disruption of PML nuclear bodies promotes the survival of cells with DNA damage," said Frappier. "Since EBNA1 is expressed in all EBV-associated tumors, including B-cell lymphomas and gastric carcinoma, these findings raise the possibility that EBNA1 could play a similar role in the development of these cancers. The cellular effects of EBNA1 in other EBV-induced cancers will require further investigation."
University of Toronto
Epstein-Barr Virus Current Events and Epstein-Barr Virus News RSSOHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.
A double-barreled immune cell approach for neuroblastoma
Adding an artificial tumor-specific receptor to immune system cells called T-lymphocytes that target a particular virus extended and improved the cells' ability to fight a form of childhood cancer called neuroblastoma, said researchers form Baylor College of Medicine and Texas Children's Hospital in a report that appears online today in the journal Nature Medicine.
NIH scientists discover crucial control in long-lasting immunity
National Institutes of Health (NIH) scientists have identified a protein that plays matchmaker between two key types of white blood cells, T and B cells, enabling them to interact in a way that is crucial to establishing long-lasting immunity after an infection.
Vaccine shows promise in preventing mono
A new study suggests that a vaccine targeting Epstein-Barr virus (EBV) may prevent infectious mononucleosis, commonly known as "mono" or "glandular fever."
OHSU research suggests America may over-vaccinate
A new study published in the New England Journal of Medicine this week by Oregon Health & Science University researchers suggests that timelines for vaccinating and revaccinating Americans against disease should possibly be reevaluated and adjusted.
Einstein scientists treat cancer as an infectious disease -- with promising results
Researchers at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that cancers can be successfully treated by targeting the viruses that cause them.
Epstein-Barr: a virtual look at a vexing virus
Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans.
An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
Researchers at the University of Pennsylvania School of Medicine have shed new light on how Kaposi's Sarcoma-associated Herpes Virus (KSHV) subverts normal cell machinery to cause cancer.
Jefferson Immunology Researchers Halt Lethal Rabies Infection in Brain
While rabies, an ancient scourge that still kills 70,000 every year in developing countries worldwide can be combated with a series of vaccines today, it nearly is always fatal when it reaches the brain.
Chronic fatigue: clues in the blood
Researchers at UNSW believe that blood may hold vital insights into what is happening in the brain of patients with chronic fatigue syndrome (CFS).
More Epstein-Barr Virus Current Events and Epstein-Barr Virus News Articles
 | Epstein Barr Virus - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and... |
| Peak Immunity: How to Fight Epstein-Barr Virus, Candida, Herpes Simplex Viruses and Other Immuno-Depressive Conditions and Win by Luc De Schepper | |
 | 21st Century Complete Medical Guide to Infectious Mononucleosis and the Epstein-Barr Virus (EBV), Authoritative Government Documents, Clinical References, ... for Patients and Physicians (CD-ROM) by PM Medical Health News This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of Infectious Mononucleosis and the Epstein-Barr Virus (EBV). This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is... |
 | Epstein-Barr Virus (Infectious Disease and Therapy) Filling a gap in the literature, this guide analyzes EBV infection and all of its associated disorders including infectious mononucleosis, Burkitt lymphoma, and Hodgkin's disease. Opening with a historical introduction, the reference progresses from molecular virology, epidemiology, immunology, and pathology to clinical presentation, diagnosis, disease detection, patient management, and vaccine... |
 | Epstein-Barr Virus |
 | Epstein-Barr Virus and Human Disease (Experimental Biology and Medicine) by P. H. Levine, D. V. Ablashi, M. Nonoyama, G. R. Pearson, R. Glaser |
| Epstein Barr virus hepatitis: case series and review.(Case Report): An article from: Southern Medical Journal by Nancy F. Crum This digital document is an article from Southern Medical Journal, published by Thomson Gale on May 1, 2006. The length of the article is 2927 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:... | |
 | Epstein-Barr Virus by Andrea Hartmann |
| Waiting to Live: The Debilitating Effects of Chronic Epstein-Barr Virus by Gregg Charles Fisher, MD Stephen E. Straus, MD James M. Oleske, Caren Heacock, Bernard Fisher | |
 | Epstein-Barr Virus and Human Cancer (Gann Monograph on Cancer Research , No 45) In this book, outstanding researchers from the US and Japan review recent progress in Epstein-Barr virus research. Most people carry EBV in memory B-cells in a latent stage. Many malignancies such as T/NK cell lymphoma, AIDS-associated B-cell lymphoma, gastric carcinoma and Hodgkin's disease have been causally linked to EBV. The development of molecular biology technique has allowed us to study... |
| © 2009 BrightSurf.com |